Review of the Tokyo Guidelines 2018: Antimicrobial Therapy for Acute Cholangitis and Cholecystitis

JAMA Surgery ◽  
2019 ◽  
Vol 154 (9) ◽  
pp. 873 ◽  
Author(s):  
Sara A. Buckman ◽  
John E. Mazuski
2007 ◽  
Vol 14 (1) ◽  
pp. 59-67 ◽  
Author(s):  
Atsushi Tanaka ◽  
Tadahiro Takada ◽  
Yoshifumi Kawarada ◽  
Yuji Nimura ◽  
Masahiro Yoshida ◽  
...  

2018 ◽  
Vol 25 (6) ◽  
pp. E6-E6 ◽  
Author(s):  
Harumi Gomi ◽  
Kohji Okamoto ◽  
Tomohiko Ukai ◽  
Tadahiro Takada

2018 ◽  
Vol 25 (1) ◽  
pp. 3-16 ◽  
Author(s):  
Harumi Gomi ◽  
Joseph S. Solomkin ◽  
David Schlossberg ◽  
Kohji Okamoto ◽  
Tadahiro Takada ◽  
...  

2021 ◽  
pp. 1-9
Author(s):  
Ramkumar Mohan ◽  
Stefanie Wei Lynn Goh ◽  
Guan Wei Tan ◽  
Yen Pin Tan ◽  
Sameer P. Junnarkar ◽  
...  

<b><i>Background:</i></b> Acute cholangitis (AC) is a common emergency with a significant mortality risk. The Tokyo Guidelines (TG) provide recommendations for diagnosis, severity stratification, and management of AC. However, validation of the TG remains poor. This study aims to validate TG07, TG13, and TG18 criteria and identify predictors of in-hospital mortality in patients with AC. <b><i>Methods:</i></b> This is a retrospective audit of patients with a discharge diagnosis of AC in the year 2016. Demographic, clinical, investigation, management and mortality data were documented. We performed a multinomial logistic regression analysis with stepwise variable selection to identify severity predictors for in-hospital mortality. <b><i>Results:</i></b> Two hundred sixty-two patients with a median age of 75.9 years (IQR 64.8–82.8) years were included for analysis. TG13/TG18 diagnostic criteria were more sensitive than TG07 diagnostic criteria (85.1 vs. 75.2%; <i>p</i> &#x3c; 0.006). The majority of the patients (<i>n</i> = 178; 67.9%) presented with abdominal pain, pyrexia (<i>n</i> = 156; 59.5%), and vomiting (<i>n</i> = 123; 46.9%). Blood cultures were positive in 95 (36.3%) patients, and 79 (83.2%) patients had monomicrobial growth. The 30-day, 90-day, and in-hospital mortality numbers were 3 (1.1%), 11 (4.2%), and 15 (5.7%), respectively. In multivariate analysis, type 2 diabetes mellitus (OR = 12.531; 95% CI 0.354–116.015; <i>p</i> = 0.026), systolic blood pressure &#x3c;100 mm Hg (OR = 10.108; 95% CI 1.094–93.395; <i>p</i> = 0.041), Glasgow coma score &#x3c;15 (OR = 38.16; 95% CI 1.804–807.191; <i>p</i> = 0.019), and malignancy (OR = 14.135; 95% CI 1.017–196.394; <i>p</i> = 0.049) predicted in-hospital mortality. <b><i>Conclusion:</i></b> TG13/18 diagnostic criteria are more sensitive than TG07 diagnostic criteria. Type 2 diabetes mellitus, systolic blood pressure &#x3c;100 mm Hg, Glasgow coma score &#x3c;15, and malignant etiology predict in-hospital mortality in patients with AC. These predictors could be considered in acute stratification and treatment of patients with AC.


HPB ◽  
2019 ◽  
Vol 21 ◽  
pp. S815
Author(s):  
E. Pando Rau ◽  
P. Alberti Delgado ◽  
L. Blanco Cuso ◽  
M. Caralt Barba ◽  
C. Dopazo Taboada ◽  
...  

2013 ◽  
Vol 21 (2) ◽  
pp. 113-119 ◽  
Author(s):  
Gang Sun ◽  
Lu Han ◽  
Yunsheng Yang ◽  
Enqiang Linghu ◽  
Wen Li ◽  
...  

2015 ◽  
Author(s):  
Paul Waltz ◽  
Matthew R Rosengart ◽  
Brian S. Zuckerbraun

The goal of this review is to discuss basic principles for the appropriate use of antibiotics in the surgical patient, largely focusing on the treatment of intra-abdominal infections. Limited pharmacologic data on common antibiotics are provided. Current reference sources and institutional guidelines should be used for specifics on dosing and administration. This review covers general principles, including treatment of surgical infections, laboratory tests, pharmacokinetics and pharmacodynamics, adverse reactions, antimicrobial resistance, and antibiotic prophylaxis in surgical patients. In addition,  specific considerations of appropriate antimicrobial therapy, such as acute cholecystitis/cholangitis, pancreatitis, appendicitis, diverticulitis, Clostridium difficile, and skin and soft tissue infections are presented. Tables list high-risk factors in intra-abdominal infections, empirical antibiotic based on risk stratification for the treatment of community-acquired intra-abdominal infections, dose adjustments for obese patients, most common isolated pathogens from intra-abdominal infections, 2005–2010, with resistance trends, adaptation of Tokyo guidelines on severity scoring and recommended antimicrobial therapy,  and recommended antibiotics for necrotizing soft tissue infections. This review contains 6 tables and 56 references


2013 ◽  
Vol 35 (4) ◽  
pp. 249-257 ◽  
Author(s):  
Toshihiko MAYUMI ◽  
Kazuki SOMEYA ◽  
Hiroki OOTUBO ◽  
Tatsuo TAKAMA ◽  
Takashi KIDO ◽  
...  

2015 ◽  
Vol 81 (5) ◽  
pp. AB365
Author(s):  
Takayoshi Nishino ◽  
Tetsuya Hamano ◽  
Izumi Shirato ◽  
Yutaka Mitsunaga ◽  
Miho Shirato ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document